Literature DB >> 16399367

Coordinate transcriptional regulation of transport and metabolism.

Jyrki J Eloranta1, Peter J Meier, Gerd A Kullak-Ublick.   

Abstract

Intestinal absorption and hepatic clearance of drugs, xenobiotics, and bile acids are mediated by transporter proteins expressed at the plasma membranes of intestinal epithelial cells and liver parenchymal cells in a polarized manner. Within enterocytes and hepatocytes, these exogenous or endogenous, potentially toxic compounds may be metabolized by phase I cytochrome P450 (CYP) and phase II conjugating enzymes. Many transporter proteins and metabolizing enzymes are subject to direct translational modification, enabling very rapid changes in their activity. However, to achieve intermediate and longer term changes in transport and enzyme activities, the genes encoding drug and bile acid transporters, as well as the CYP and conjugating enzymes, are regulated by a complex network of transcriptional cascades. These are typically mediated by specific members of the nuclear receptor family of transcription factors, particularly FXR, SHP, PXR, CAR, and HNF-4alpha. Most nuclear receptors are activated by specific ligands, including numerous xenobiotics (PXR, CAR) and bile acids (FXR). The fine-tuning of transcriptional control of drug and bile acid homeostasis depends on regulated interactions of specific nuclear receptors with their target genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16399367     DOI: 10.1016/S0076-6879(05)00028-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  11 in total

Review 1.  New perspectives for the treatment of cholestasis: lessons from basic science applied clinically.

Authors:  James L Boyer
Journal:  J Hepatol       Date:  2006-12-18       Impact factor: 25.083

2.  How bile acids confer gut mucosal protection against bacteria.

Authors:  Alan F Hofmann; Lars Eckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

3.  Preservation of hepatic phenotype in lentiviral-transduced primary human hepatocytes.

Authors:  Stephanie M Zamule; Stephen C Strom; Curtis J Omiecinski
Journal:  Chem Biol Interact       Date:  2008-04-08       Impact factor: 5.192

Review 4.  Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities.

Authors:  Curtis J Omiecinski; John P Vanden Heuvel; Gary H Perdew; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2010-11-08       Impact factor: 4.849

Review 5.  Bile acid transporters: structure, function, regulation and pathophysiological implications.

Authors:  Waddah A Alrefai; Ravinder K Gill
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

Review 6.  Primary biliary cholangitis: pathogenesis and therapeutic opportunities.

Authors:  Aliya F Gulamhusein; Gideon M Hirschfield
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-09       Impact factor: 46.802

Review 7.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 8.  Hepatic drug transporters and nuclear receptors: regulation by therapeutic agents.

Authors:  Aldo-D Mottino; Viviana-A Catania
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

9.  Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease.

Authors:  April D Lake; Petr Novak; Craig D Fisher; Jonathan P Jackson; Rhiannon N Hardwick; D Dean Billheimer; Walter T Klimecki; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2011-07-07       Impact factor: 3.922

10.  A PXR-mediated negative feedback loop attenuates the expression of CYP3A in response to the PXR agonist pregnenalone-16α-carbonitrile.

Authors:  Ian Bailey; G Gordon Gibson; Kathryn Plant; Mark Graham; Nick Plant
Journal:  PLoS One       Date:  2011-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.